Skip to main content

Table 5 Univariate and multivariate analyses for lung cancer patients on disease‐free survival in the GSE30219

From: CLEC3B as a potential diagnostic and prognostic biomarker in lung cancer and association with the immune microenvironment

Variable Univariate analysis Multivariate analysis
HR (95% CI) p-value HR (95% CI) p-value
Age (≤ 55 vs > 55 years) 1.027 (1.009–1.045) 0.003 1.029 (1.010–1.048) 0.003
Gender
 Female vs male 0.746 (0.433-1.285) 0.290   
T stage
 T1 vs T2 vs T3 vs T4 1.882 (1.587–2.232) 0.000 1.309 (1.027–1.670) 0.030
N stage
 N0 vs N1 vs N2 vs N4 2.618 (1.791–2.624) 0.000 1.652 (1.259–2.169) 0.000
M stage
 M0 vs M1 3.837 (1.408–10.456) 0.009 3.951 (1.428–10.933) 0.008
CLEC3B expression
 High vs low 0.442 (0.300–0.650) 0.000 0.655 (0.430–0.996) 0.048
  1. CI, confidence interval; HR, hazard ratio